DK0392803T3 - Hidtil ukendte forbindelser - Google Patents

Hidtil ukendte forbindelser

Info

Publication number
DK0392803T3
DK0392803T3 DK90303852T DK90303852T DK0392803T3 DK 0392803 T3 DK0392803 T3 DK 0392803T3 DK 90303852 T DK90303852 T DK 90303852T DK 90303852 T DK90303852 T DK 90303852T DK 0392803 T3 DK0392803 T3 DK 0392803T3
Authority
DK
Denmark
Prior art keywords
group
alkyl
hitherto unknown
unknown compounds
chem
Prior art date
Application number
DK90303852T
Other languages
English (en)
Inventor
Barry Sidney Orlek
Steven Mark Bromidge
Steven Dabbs
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908365A external-priority patent/GB8908365D0/en
Priority claimed from GB898923299A external-priority patent/GB8923299D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of DK0392803T3 publication Critical patent/DK0392803T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK90303852T 1989-04-13 1990-04-10 Hidtil ukendte forbindelser DK0392803T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908365A GB8908365D0 (en) 1989-04-13 1989-04-13 Novel compounds
GB898923299A GB8923299D0 (en) 1989-10-16 1989-10-16 Novel compounds

Publications (1)

Publication Number Publication Date
DK0392803T3 true DK0392803T3 (da) 2004-10-18

Family

ID=26295213

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90303852T DK0392803T3 (da) 1989-04-13 1990-04-10 Hidtil ukendte forbindelser

Country Status (13)

Country Link
US (1) USRE35593E (da)
EP (1) EP0392803B1 (da)
JP (3) JP2665818B2 (da)
KR (1) KR0185378B1 (da)
AT (1) ATE269330T1 (da)
CA (1) CA2014379C (da)
DE (1) DE69034146T2 (da)
DK (1) DK0392803T3 (da)
ES (1) ES2219636T3 (da)
HK (1) HK1012365A1 (da)
NZ (1) NZ233290A (da)
PT (1) PT93753B (da)
SG (1) SG48315A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003435A1 (en) * 1990-08-24 1992-03-05 Beecham Group Plc Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them
GB9019095D0 (en) * 1990-09-01 1990-10-17 Beecham Group Plc Novel compounds
US5356914A (en) * 1990-10-12 1994-10-18 Beecham Group P.L.C. 1,2,5,6-tetrahydropyridine oxime derivatives
WO1992011261A1 (en) * 1990-12-21 1992-07-09 Merck Sharp & Dohme Limited 4-azatricyclo[2.2.1.02,6]heptanes and pharmaceutical compositions
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9409718D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9421472D0 (en) * 1994-10-25 1994-12-07 Smithkline Beecham Plc Novel methods
AR004178A1 (es) * 1995-07-29 1998-11-04 Smithkline Beecham Plc Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.
AU751607B2 (en) * 1995-07-29 2002-08-22 Smithkline Beecham Plc Method of treatment of dementia
AU722015B2 (en) * 1996-05-13 2000-07-20 Zeneca Limited Bicyclic amines
GB9615628D0 (en) * 1996-07-25 1996-09-04 Smithkline Beecham Plc Formulation
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
US20010003588A1 (en) * 1996-09-12 2001-06-14 Smithkline Beecham Corporation Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2.]oct-3-yl)acetonitrile monohydrochloride
US6284771B1 (en) * 1997-04-11 2001-09-04 Eli Lilly And Company Method for treating schizophrenia
GB9815383D0 (en) * 1998-07-15 1998-09-16 Smithkline Beecham Plc Novel method of treatment
KR20030021641A (ko) * 2001-09-07 2003-03-15 안병로 투명비누 자가제조용 키트 및 상기 키트를 이용한투명비누 자가제조방법
US7678363B2 (en) * 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
GB0607946D0 (en) * 2006-04-21 2006-05-31 Minster Res The Ltd Mono and combination therapy
GB0607952D0 (en) * 2006-04-21 2006-05-31 Minster Res Ltd Novel treatment
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
KR102287645B1 (ko) 2018-12-18 2021-08-06 한화솔루션 주식회사 실리카계 촉매를 이용한 배위-음이온 개환 중합에 의한 폴리아마이드의 제조방법 및 이에 의해 제조된 폴리아마이드

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563225B2 (en) * 1982-04-14 1987-07-02 Alizyme Therapeutics Limited I-aza bicyclic compounds
FR2531955A1 (fr) * 1982-08-17 1984-02-24 Pharmuka Lab Nouveau procede de preparation de derives de la quinuclidine substitues en position 3
IL81610A (en) * 1986-02-27 1990-12-23 Roussel Uclaf Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them
DE3789039T2 (de) * 1986-06-27 1994-06-09 Beecham Group Plc Verbrückte bicyclische N-heterocyclische Verbindungen.
GB8615785D0 (en) * 1986-06-27 1986-08-06 Beecham Group Plc Compounds
US4786648A (en) * 1986-12-08 1988-11-22 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
US4710508A (en) * 1986-12-08 1987-12-01 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
US4798841A (en) * 1987-03-31 1989-01-17 Warner-Lambert Company Tetrahydropyridine oxime cholinergic agents and method of treatment
ATE133415T1 (de) * 1987-04-15 1996-02-15 Beecham Group Plc Am brückenkopf substituierte azabicyclenderivate
IT1203971B (it) * 1987-04-24 1989-02-23 Roussel Maestretti Spa Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti
IT1222529B (it) * 1987-08-21 1990-09-05 Roussel Maestretti Spa Derivati dell' ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali
IT1222526B (it) * 1987-08-21 1990-09-05 Roussel Maestretti Spa Derivati dell' ossima della 1,2,5,6-tetraidropiridin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali
DE3738521C1 (de) * 1987-11-13 1988-12-01 Delta Getriebe Gmbh Planetengetriebe
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
IT1233446B (it) * 1987-12-30 1992-04-01 Roussel Maestretti Spa Derivati della 3 piperidinocarbaldeide ossima, loro procedimento di preparazione e loro applicazione come farmaci
EP0338723B1 (en) * 1988-04-15 1993-08-04 Beecham Group Plc Novel compounds
IT1227436B (it) * 1988-10-28 1991-04-11 Roussel Maestretti Spa Derivati di 1-azabicicloalcani, loro procedimento di preparazione e loro applicazione come farmaci
US4937239A (en) * 1989-02-13 1990-06-26 Warner-Lambert Company Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents
EP0402056A3 (en) * 1989-06-06 1991-09-04 Beecham Group p.l.c. Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JP2665818B2 (ja) 1997-10-22
JPH09188679A (ja) 1997-07-22
AU619969B2 (en) 1992-02-06
CA2014379C (en) 2000-02-08
PT93753A (pt) 1990-11-20
JPH037285A (ja) 1991-01-14
NZ233290A (en) 1992-06-25
JPH09188678A (ja) 1997-07-22
EP0392803B1 (en) 2004-06-16
EP0392803A1 (en) 1990-10-17
ES2219636T3 (es) 2004-12-01
JP2913466B2 (ja) 1999-06-28
KR900016211A (ko) 1990-11-12
USRE35593E (en) 1997-08-19
DE69034146D1 (de) 2004-07-22
CA2014379A1 (en) 1990-10-13
AU5315990A (en) 1990-10-18
DE69034146T2 (de) 2005-07-14
SG48315A1 (en) 1998-04-17
PT93753B (pt) 1996-08-30
ATE269330T1 (de) 2004-07-15
JP2913467B2 (ja) 1999-06-28
KR0185378B1 (ko) 1999-05-01
HK1012365A1 (en) 1999-07-30

Similar Documents

Publication Publication Date Title
DK0392803T3 (da) Hidtil ukendte forbindelser
DK254587D0 (da) Positionsspecifikke alkyleringsmidler
DE69033935T2 (de) Bis(3,4-Dialkylbenzyliden)sorbitolacetale und diese enthaltende Zusammensetzungen
DE59408068D1 (de) Substituierte 1-Phenyl-oxazolidin-2-on Derivate deren Herstellung und der Verwendung als Adhäsionsrezeptor-Antagonisten
DK202388D0 (da) Hidtil ukendte forbindelser
DK38982A (da) Fremgangsmaade til fremstilling af 2-penemforbindelser
PL285683A1 (en) Method of obtaining novel amines
SE8603099D0 (sv) Distamycin derivatives and process for their preparation
SE8604950D0 (sv) Dementia-improving and therapeutic agents
ATE35137T1 (de) Thieno(2,3-d)pyrimidin-derivate und deren salze.
NL930057I2 (nl) Aromatische verbindingen.
FI870090A0 (fi) Laongkedjade alkylresorcinolfosfiter.
ES2080975T3 (es) Derivados de imidazol-2-ona sustituidos y procedimiento para su preparacion.
SE7605190L (sv) Nya tiazoliner
PT87050A (pt) Process for preparing indane sulfonamides antiarrhythmic agents
NO900732L (no) Arylalkylaminforbindelser.
SE8205256L (sv) Tricykliska kinazolinoner
DE3470882D1 (en) N-substituted tetrahydrothiazines, process for their preparation, and their use as pesticides